Related Experiment Video
Updated: Mar 27, 2026

Rapid Analysis of Chromosome Aberrations in Mouse B Lymphocytes by PNA-FISH
Published on: August 19, 2014
The leukemic oncoprotein NPM1-RARA inhibits TP53 activity
Erin M Swaney1, Anuja Chattopadhyay1, Irina Abecassis1
1a Department of Medicine , University of Pittsburgh, and University of Pittsburgh Cancer Institute, University of Pittsburgh , Pittsburgh , PA , USA.
The NPM1-RARA fusion protein in acute promyelocytic leukemia (APL) reduces TP53 levels, hindering its function. This impairment of the TP53 tumor suppressor is crucial for APL development and resistance to cell death.
Area of Science:
- Molecular Biology
- Cancer Research
- Hematology
Background:
- Acute promyelocytic leukemia (APL) is characterized by the t(5;17) translocation.
- This translocation results in the fusion of NPM1 and RARA genes.
- The NPM1-RARA fusion protein is central to APL pathogenesis.
Purpose of the Study:
- To investigate the impact of NPM1-RARA on TP53 protein levels and function.
- To elucidate the role of TP53 impairment in NPM1-RARA-driven leukemogenesis.
- To identify novel therapeutic targets in APL.
Main Methods:
- Ectopic expression of NPM1-RARA in target cells.
- Assessment of TP53 protein levels and activity.
- Analysis of TP53-dependent transcription.
- Evaluation of cellular resistance to apoptotic stimuli.
Main Results:
- Ectopic NPM1-RARA expression significantly decreased TP53 protein levels.
- NPM1-RARA impaired TP53-dependent transcriptional activity.
- Cells expressing NPM1-RARA exhibited increased resistance to apoptotic stimuli.
- TP53 was identified as a novel target of NPM1-RARA.
Conclusions:
- The NPM1-RARA fusion protein impacts leukemogenesis by targeting the TP53 tumor suppressor.
- Impairment of TP53 function is critical for establishing the APL phenotype.
- Targeting the NPM1-RARA interaction with TP53 may offer therapeutic strategies for APL.
More Related Videos
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Intrinsic Apoptotic Pathway
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

